REINVENTING DRUG DISCOVERY THROUGH CHEMICAL ......REINVENTING DRUG DISCOVERY 2019 THROUGH CHEMICAL...

Post on 12-Oct-2020

2 views 0 download

Transcript of REINVENTING DRUG DISCOVERY THROUGH CHEMICAL ......REINVENTING DRUG DISCOVERY 2019 THROUGH CHEMICAL...

This symposium is brought to you through collaboration between the University of Michigan and Cayman Chemical.

REINVENTING DRUG DISCOVERY THROUGH CHEMICAL BIOLOGY20

19

KEYNOTE SPEAKERS:

ADDITIONAL SPEAKERS:

CALL FOR ABSTRACTS

MAY 16, 2019 10:00 am – 4:00 pm

UNIVERSITY OF MICHIGAN 1200 CHEMISTRY BUILDING 930 N. UNIVERSITY AVENUE, ANN ARBOR, MI 48109

www.sites.google.com/prod/umich.edu/chembio2019/home Registration Deadline · May 15th

A catered lunch will be provided to all who pre-register by May 12th

Abstracts should be submitted via the registration form on the symposium website

Friday, May 10th

4 ft (height) x 6 ft (width) MAXIMUM dimensions

Abstract guidelines:

Visit www.sites.google.com/prod/umich.edu/chembio2019/home for more details

Abstract submission:

Submission deadline:

Poster guidelines:

Dusty Maly, PhD Professor of Chemistry, University of Washington, Seattle, WAModulating Phosphotransferase-Independent Kinase Functions from a Distance

Amanda Garner, PhDAssistant Professor of Medicinal Chemistry, University of Michigan, Ann Arbor, MIIdentification of Kinase-Targeted Drug Combinations using Chemoproteomics

Jolanta Grembecka, PhDAssociate Professor of Pathology, University of Michigan, Ann Arbor, MIDevelopment of New Targeted Therapies for Leukemia

Nouri Neamati, PhDJohn G. Searle Professor of Medicinal Chemistry, University of Michigan, Ann Arbor, MITargeting Protein Disulfide Isomerase in Cancer

Matthew Soellner, PhDResearch Assistant Professor of Internal Medicine, University of Michigan, Ann Arbor, MISelective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase

Daniel Nomura, PhD Associate Professor of Chemistry, Molecular & Cell Biology, and Nutritional Sciences & Toxicology, University of California-Berkeley, Berkeley, CAReimaging Druggability using Chemoproteomic Platforms

Abstracts should include a title, and the presenting author’s name should be listed first. The body must be no more than 250 words in length. Two short talks will be chosen from abstract submissions.